Bladder-Cancer-banner-NEW v2
 

Please feel free to forward to fellow researchers and share the news of our journal

Dear Colleague,

We are delighted to announce the publication of Volume 4, Issue 3 of Bladder Cancer (BLC). The full contents are freely available online and can be browsed in full below.

This issue hosts an outstanding selection of articles, including a review of antibody–drug conjugates, a report of the last International Bladder Cancer Network (IBCN) meeting and, from the editors of the regular journal sections, there are new Challenging Case, Clinical Trials Corner, and Paper Alert contributions.

BLC-purple-divider

Call for Papers

As a member of our research community, we would like to invite you to contribute your own research articles to Bladder Cancer, which offers contributing authors many benefits:

• First class Editorial Board
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press) on acceptance
• Articles are currently published Open Access with no article processing fee

Submit your manuscript online via msTracker
View detailed Instructions to Authors
Aims and Scope

We look forward to working with you.

Best wishes,

Editors-in-Chief

Seth P. Lerner, MD
Scott Department of Urology
Baylor College of Medicine
Houston, Texas, USA
Email: blc@iospress.com

Dan Theodorescu, MD, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California, USA
Email: blc@iospress.com

BLC-purple-divider

All articles are freely available to all readers

Antibody-Drug Conjugates in Bladder Cancer
Vlachostergios, Panagiotis J. | Jakubowski, Christopher D. | Niaz, Muhammad J. | Lee, Aileen | Thomas, Charlene | Hackett, Amy L. | Patel, Priyanka | Rashid, Naureen | Tagawa, Scott T.

Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome
Huang, Dora | Matin, Surena F. | Lawrentschuk, Nathan | Roupret, Morgan

A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR Inhibition
Goodspeed, Andrew | Jean, Annie | Theodorescu, Dan | Costello, James C.

Fatty Acid Patterns Detected By Ambient Ionization Mass Spectrometry in Canine Invasive Urothelial Carcinoma From Dogs of Different Breeds
D’Hue, Cedric A. | Dhawan, Deepika | Peat, Tyler | Ramos-Vara, José | Jarmusch, Alan | Knapp, Deborah W. | Cooks, R. Graham

Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer
Karsh, Lawrence | Shore, Neal | Soloway, Mark | Bhat, Gajanan | Reddy, Guru | Leu, Szu-Yun | Witjes, J. Alfred

Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study
Jochems, Sylvia H.J. | van Osch, Frits H.M. | Reulen, Raoul C. | van Hensbergen, Mitch | Nekeman, Duncan | Pirrie, Sarah J. | Wesselius, Anke | van Schooten, Frederik J. | James, Nicholas D. | Wallace, D. Michael A. | Bryan, Richard T. | Cheng, K.K. | Zeegers, Maurice P.

Radiation Therapy as Definitive Local Treatment in Patients with Limited-Stage Small Cell Carcinoma of the Bladder: Does total dose matter?
Germino, Elizabeth | Fischer-Valuck, Benjamin W. | Rudra, Soumon | Rao, Yuan James | Contreras, Jessika | Abraham, Christopher | Michalski, Jeff | Gay, Hiram

Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients
Vartolomei, Liliana | Ferro, Matteo | Mirone, Vincenzo | Shariat, Shahrokh F. | Vartolomei, Mihai Dorin

Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays
Jakobsson, Lovisa | Chebil, Gunilla | Marzouka, Nour-Al-Dain | Liedberg, Fredrik | Sjödahl, Gottfrid

New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network
Black, Peter C. | Goebell, Peter J. | Kamat, Ashish M. | Nawroth, Roman | Schmitz-Dräger, Bernd J.

Challenging Cases in Urothelial Cancer
Soloway, Mark S.

Clinical Trials Corner
Agarwal, Piyush K. | Sternberg, Cora N.

Paper Alert: Financial Toxicity of Having Bladder Cancer
Messing, Edward M.

BLC-purple-divider

Most Viewed BLC Articles, April–June 2018

Listing only papers published in 2017 & 2018 so you can read the most popular recent content

Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer (Research Article in Vol.3, Iss.4, 2017)
Moran, George W. | Li, Gen | Robins, Dennis J. | Matulay, Justin T. | McKiernan, James M. | Anderson, Christopher B.

Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer (Review Article in Vol.4, Iss.1, 2018)
Todenhöfer, Tilman | Struss, Werner J. | Seiler, Roland | Wyatt, Alexander William | Black, Peter C.

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer (Review Article in Vol.4, Iss.1, 2018)
Sherif, Amir | Winerdal, Malin | Winqvist, Ola

Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines (Research Article in Vol.4, Iss.2, 2018)
Zuiverloon, Tahlita C.M. | de Jong, Florus C. | Costello, James C. | Theodorescu, Dan

Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention (Review Article in Vol.4, Iss.2, 2018)
Zareba, Piotr | Duivenvoorden, Wilhelmina C.M. | Pinthus, Jehonathan H.

BLC-purple-divider

Bladder Cancer Reaching International Audiences

BCAN2018 crop final

BCAN Think Tank (Denver) & BCa18 (Munich)

Bladder Cancer has been traveling the world in recent months, with information about the journal available to delegates at conferences where members of the Editorial Board spread word of the excellent research published in the pages of our journal. BLC's Associate Publisher, Wilbert van der Sluijs, has also been out on the road promoting the journal and networking with the BLC audience, attending the EAU Update on Bladder Cancer meeting (BCa18) in Munich in June and the BCAN Think Tank in Denver earlier this month (pictured). Just a reminder that you can follow the discussion and activities at such events and conferences without even leaving home through the journal's Twitter feed.

BLC-purple-divider

BCAN News

BCAN-free-event-Oct

Bladder Cancer Summit

12–13 October 2018

A free conference for patients and families will take place in October in Houston, TX, USA. Organized by BCAN, this event will provide an opportunity to learn about the role and impact of clinical trials in the advancement of bladder cancer treatment. It will also provide opportunity to hear leading bladder cancer experts discuss recent upcoming bladder cancer research advances. Read more at the BCAN website.

BLC-purple-divider

Upcoming Meetings

Global Congress on Bladder Cancer

20–21 September 2018 | Madrid, Spain

The 2018 congress focuses on topics that have an impact on day-to-day clinical practice. This will be of interest to all specialties dealing with bladder cancer. The multidisciplinary and internationally influential faculty will bring you interactive case discussions and state-of-the-art presentations on diagnosis and treatment of patients with various stages of bladder cancer. For more details, view the event website here.

***

IBCN Annual Meeting 2018

11–13 October 2018 | Rotterdam, the Netherlands

The upcoming IBCN Annual Meeting will focus on hot topics in clinical and translational bladder cancer research. The event ensures time for delegate discussions alongside interactive poster sessions and group break-out sessions in collaboration with industry partners. This meeting is only open to IBCN members; for details about becoming a member, visit the IBCN website.

BLC-purple-divider

Please Share the BLC Newsletter With Your Colleagues

Help Spread the News of BLC!

If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the visual or access the sign-up link here.

BLC has an active social media presence. If you are not yet interacting with the journal on social media, why not take the time today to follow us on Twitter?

Be part of the discussion!

BLC-purple-divider
 
 
Powered by Mad Mimi®A GoDaddy® company